Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GA101-miniCHOP in elderly unfit patients with diffuse large B-cell lymphoma
2014-005697-10Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Feb 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of obinutuzumab in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by Fondazione Italiana Linfomi. Started Feb 2015; status: completed.
02
Drugs
obinutuzumab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on 2014-005697-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005697-10.